(Q34473395)

English

Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells (English)

1 reference

Europe PubMed Central

2 August 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

prostaglandin E2

1 reference

based on heuristic

inferred from title

neoplastic invasiveness

1 reference

based on heuristic

inferred from title

author name string

Chang Han

1

1 reference

Europe PubMed Central

2 August 2017

George K Michalopoulos

2

1 reference

Europe PubMed Central

2 August 2017

Tong Wu

3

1 reference

Europe PubMed Central

2 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2006

1 reference

Europe PubMed Central

2 August 2017

Journal of Cellular Physiology

1 reference

Europe PubMed Central

2 August 2017

207

1 reference

Europe PubMed Central

2 August 2017

1

1 reference

Europe PubMed Central

2 August 2017

261-270

1 reference

Europe PubMed Central

2 August 2017

Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.

1 reference

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M500562200

30 December 2023

Transforming growth factor-beta (TGF-beta) activates cytosolic phospholipase A2alpha (cPLA2alpha)-mediated prostaglandin E2 (PGE)2/EP1 and peroxisome proliferator-activated receptor-gamma (PPAR-gamma)/Smad signaling pathways in human liver cancer ce

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M404852200

Prostanoid receptors in intestinal epithelium: selective expression, function, and change with inflammation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Hepatoma cell migration through a mesothelial cell monolayer is inhibited by cyclic AMP-elevating agents via a Rho-dependent pathway

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

EGFR signal transactivation in cancer cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Elevated levels of prostaglandin E2 in the liver of rats fed a choline deficient diet: possible involvement in liver tumor promotion

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Genetic and pharmacological analysis of prostanoid receptor function

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Prostaglandin E(2) stimulates rat and human colonic mucin exocytosis via the EP(4) receptor

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Possible involvement of arachidonic acid metabolism in phenobarbital promotion of hepatocarcinogenesis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Malignant transformation and EGFR activation of immortalized mouse liver epithelial cells caused by HBV enhancer-X from a human hepatocellular carcinoma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Inhibition by acetylsalicylic acid, a cyclo-oxygenase inhibitor, and p-bromophenacylbromide, a phospholipase A2 inhibitor, of both cirrhosis and enzyme-altered nodules caused by a choline-deficient, L-amino acid-defined diet in rats.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Prevention by acetylsalicylic acid of liver cirrhosis and carcinogenesis as well as generations of 8-hydroxydeoxyguanosine and thiobarbituric acid-reactive substances caused by a choline-deficient, L-amino acid-defined diet in rats.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Evidence that indomethacin reversibly inhibits cell growth in the G1 phase of the cell cycle

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Transactivation joins multiple tracks to the ERK/MAPK cascade

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Inhibitory effect of the non-steroidal anti-inflammatory drugs, indomethacin and piroxicam on 2-acetylaminofluorene-induced hepatocarcinogenesis in male ACI/N rats.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Prostanoid receptors: subtypes and signaling

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Cyclooxygenase-2 inhibitors suppress the growth of human hepatocellular carcinoma implants in nude mice

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Prevention by inhibitors of arachidonic acid cascade of liver carcinogenesis, cirrhosis and oxidative DNA damage caused by a choline-deficient, L-amino acid-defined diet in rats.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

85-kDa cPLA(2) plays a critical role in PPAR-mediated gene transcription in human hepatoma cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Identifiers

10.1002/JCP.20560

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

reason for deprecated rank

unchecked identifier

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34473395&oldid=2073456456"